Confronted with more than 50,000 asbestos related claims linked to its baby products, Johnson & Johnson’s (J&J) recent legal maneuvers have brought into focus the intricate dance between corporate solvency and mass liability. Despite prevailing in the majority of these claims, the prospect of facing another $2.1 billion verdict looms large. Consequently, J&J has put forth an $8.9 billion settlement offer, aiming to resolve all current and future claims and bring closure to this asbestos...